ondansetron has been researched along with Hyperglycemia, Postprandial in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal.
Excerpt | Relevance | Reference |
---|---|---|
"Quipazine-treated, hyperglycemic animals did not show any increase in plasma insulin levels." | 1.33 | Hyperglycemia induced by pharmacological activation of central serotonergic pathways depends on the functional integrity of brain CRH system and 5-HT3 receptors. ( Barros, D; Carvalho, F; de Castro-E-Silva, E; Fregoneze, J; Rezende, E; Silva, J; Soares, M, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carvalho, F | 1 |
Barros, D | 1 |
Silva, J | 1 |
Rezende, E | 1 |
Soares, M | 1 |
Fregoneze, J | 1 |
de Castro-E-Silva, E | 1 |
1 other study available for ondansetron and Hyperglycemia, Postprandial
Article | Year |
---|---|
Hyperglycemia induced by pharmacological activation of central serotonergic pathways depends on the functional integrity of brain CRH system and 5-HT3 receptors.
Topics: Animals; Blood Glucose; Corticotropin-Releasing Hormone; Hyperglycemia; Indazoles; Insulin; Male; On | 2005 |